European stocks on Monday sagged on concerns over the progress of U.S.-China trade talks and violence in Hong Kong.
The company reported third-quarter 2019 operating results and deepened its relationship with Gilead Sciences.
GLPG earnings call for the period ending September 30, 2019.
Galapagos NV (NASDAQ:GLPG) announced that the FDA has granted Fast Track designation to its pipeline candidate GLPG1972/S201086 for the treatment of osteoarthritis (OA)....
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive...
Investors are always looking for stocks that are poised to beat at earnings season and Galapagos NV (NASDAQ:GLPG) may be one such company. The firm has earnings coming up pretty...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Technical Indicators||Strong Sell||BUY||BUY||Strong Buy||Strong Buy|
|Summary||Strong Sell||Buy||Buy||Strong Buy||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Three Outside Down||30||Current|
|Deliberation Bearish||1W||1||Nov 03, 2019|
|Doji Star Bearish||1W||1||Nov 03, 2019|
|Engulfing Bearish||30||2||Nov 13, 2019 10:30AM|
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In addition, the Company’s mission is to develop a number of medicines based on the discovery of novel targets. Galapagos NV also discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. Galapagos aims to develop small molecules that inhibit these targets, restore the balance and thereby positively influence the course of the disease.Read More
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
|Securities Investor Protection Corporation (United States)||$0||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.